Indogulf Cropsciences Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹105 - ₹111
- Lot size
- 135 shares
- Issue amount
- ₹200 cr
- Total subscription
- 25.99×
- Opens
- 26 Jun 2025
- Closes
- 30 Jun 2025
- Allotment
- 1 Jul 2025
- Listing
- 3 Jul 2025
Offer at a glance
Issue overview
- Issue size
- 1,80,18,017 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹14,175
- Fresh issue
- ₹160 cr
- Offer for sale
- ₹40 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,985
- Issue type
- Bookbuilding IPO
- Shares before issue
- 4,87,87,456
- Shares after issue
- 6,32,01,870
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 135 | ₹14,985 |
| sHNI | 14 | 1,890 | ₹2,09,790 |
| bHNI | 67 | 9,045 | ₹10,03,995 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| RETAIL | 45,312 | 6,99,888 |
| HNIs(10L +) | 925 | 49,697 |
| HNIs (2-10L) | 462 | 20,466 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 38.8 | 1,326.22 |
| RETAIL | 67.9 | 1,048.78 |
| HNIs 2+ | 9.7 | 429.35 |
| HNIs 10+ | 19.4 | 1,042.6 |
| EMPLOYEES | 6.66 | 7.69 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Dec-24 | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|---|
| EPS | 5.1 | 12 | 9.53 | 11.21 |
| ROE | 8.17 | 12.19 | 11.03 | 14.6 |
| ROCE | 12.96 | 18.82 | 17.77 | 20.26 |
| RONW | 0 | 0 | 0 | 0 |
| PRE IPO(PE) | 0 | 0 | 0 | 0 |
| POST IPO(PE) | 0 | 0 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Indogulf Cropsciences Limited, established in 1993, is an Indian company involved in the production of crop protection products, plant nutrients, and biologicals. In 2019, it began manufacturing Spiromesifen technical with 96.5% purity and became one of the first local producers of Pyrazosulfuron Ethyl technical with 97% purity. The company operates four manufacturing units spread across approximately twenty acres in Samba (Jammu & Kashmir) and Nathupur and Barwasni in Haryana. It has a strong sales presence in 22 Indian states and 3 Union Territories, supported by 169 business partners, 5,772 distributors, and 129 international partners across 34 countries. Its flexible and multi-purpose production facilities allow it to adapt quickly to different customer needs. The company benefits from high entry barriers in the agrochemical sector, such as high costs and complex regulatory approvals. Indogulf's product range includes plant nutrients like specialty fertilizers and soil health products that improve fertility, root growth, and crop yield. Its crop protection offerings consist of insecticides, fungicides, herbicides, and bio-stimulants that help protect crops from pests, diseases, and weeds. The company also provides biologicals such as bio-fertilizers and bio-stimulants to enhance nutrient uptake, stress tolerance, and sustainable farming. Popular products in this category include Biogold, Indo Breeza, and Indo Mychoriza. As of August 31, 2024, the company employed 640 permanent staff members.
Strengths
- Strong Domestic & Global Distribution – Present in 22 states, 3 UTs, and 34 countries with 5,700+ distributors and 169 partners.
- In-House Manufacturing Advantage – Facilities in J&K and Haryana offer better control over quality, cost, and supply chain.
- Advanced R&D and Innovation – Known for developing products like Spiromesifen, backed by strong technical research and innovation.
Risk factors
- Quality Control Risk – Any failure to meet quality standards may cause order losses, customer distrust, and impact revenue.
- Brand Reputation Risk – Negative publicity or product issues can harm brand image and reduce market share.
- Low Capacity Utilization Risk – Unused production capacity can raise costs and lower profits, affecting growth.
Promoters
1. Om Prakash Aggarwal
2. Sanjay Aggarwal
3. Anshu Aggarwal
4. Arnav Aggarwal
Registrar & documents
Lead manager
Systematix Corporate Services Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
501, Gopal Heights Plot No - D-9, Netaji Subhash Place Delhi, New Delhi, 110034
+91 11 4004 0417
[email protected]Company website ↗Understanding IGCL IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.